InVivo Therapeutics Holdings Corp.

NVIV

US46186M6057

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 12:12:45 01/06/2024 am IST			5-day change	1st Jan Change
0.3983 ^USD	+2.12%		+2.13%	-45.44%

16/04	North American Morning Briefing : Powell Comments, -2-	DJ
02/04	North American Morning Briefing : Stocks Seen -2-	DJ

InVivo: Q3 Earnings Snapshot

November 09, 2022 at 12:38 am IST

CAMBRIDGE, Mass. (AP) _ InVivo Therapeutics Holdings Corp. (NVIV) on Monday reported a loss of $2.8 million in its third quarter.

The Cambridge, Massachusetts-based company said it had a loss of $1.98 per share.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVIV at https://www.zacks.com/ap/NVIV

Latest news about InVivo Therapeutics Holdings Corp.

North American Morning Briefing : Powell Comments, -2-	16/04	DJ
North American Morning Briefing : Stocks Seen -2-	02/04	DJ
North American Morning Briefing : Markets Steady -2-	26/03	DJ
North American Morning Briefing : Stock Futures -2-	19/03	DJ
InVivo Therapeutics Holdings Corp.(OTCPK:NVIV.Q) dropped from NASDAQ Composite Index	12/02	CI
InVivo Therapeutics Holdings Corp.(NasdaqCM:NVIV) dropped from S&P TMI Index	06/02	CI
Motion for Joint Administration Approved for Invivo Therapeutics Corporation	06/02	CI
Motion for Asset Sale Filed by Invivo Therapeutics Corporation	01/02	CI
Motion for Joint Administration Filed by Invivo Therapeutics Corporation	01/02	CI
Invivo Therapeutics Corporation Filed for Bankruptcy	01/02	CI
Invivo Therapeutics Holdings Corp. Announces Resignation of Daniel R. Marshak from the Board of Directors	23/11	CI
InVivo to open Saudi office as adapts to global grain shifts	15/11	RE
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11	CI
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/23/10	CI
Australia's United Malt agrees to $1 bln takeover offer from France's InVivo	03/23/03	RE
Trio of French businessmen plan counter-offer for Casino	08/23/08	RE
Trio of French businessmen plan counter-offer for Casino	08/23/08	RE
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	13/23/13	CI
France's InVivo offers close to $1 bln for Australia's United Malt	28/23/28	RE
France's InVivo placed bid for Australia's United Malt -report	27/23/27	RE
Sector Update: Healthcare Stocks Stumble Late	10/23/10	MT
Sector Update: Health Care	10/23/10	MT
Top Midday Decliners	10/23/10	MT
InVivo Therapeutics Says Study of Neuro-Spinal Scaffold Device Didn't Achieve Primary Endpoint; Shares Fall	09/23/09	MT
InVivo Therapeutics Says Study of Neuro-Spinal Scaffold Device Didn't Achieve Primary Endpoint; Shares Halted	09/23/09	MT

Chart InVivo Therapeutics Holdings Corp.

Duration

Period

Chart InVivo Therapeutics Holdings Corp.

More charts

InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by-side, healing by supporting the surrounding tissue after injury, minimizing the expansion of areas of necrosis, and providing a biomaterial substrate for the body's own healing/repair processes following injury. It is composed of two biocompatible and bioresorbable polymers that are cast to form a porous investigational product: Poly lactic-co-glycolic acid and Poly-L-Lysine. Poly lactic-co-glycolic acid is a polymer that is used in resorbable sutures and provides biocompatible support for Neuro-Spinal Scaffold implants and Poly-L-Lysine is a positively charged polymer used to coat surfaces.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INVIVO THERAPEUTICS HOLDINGS CORP.	-45.44%	1.24M
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.48%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.6B